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Abstract
316L-type stainless steel is a raw material mostly used for manufacturing metallic coronary
stents. The purpose of this study was to examine the chemical, wettability, cytotoxic and
haemocompatibility properties of 316L stainless steel stents which were modified by plasma
polymerization. Six different polymeric compounds, polyethylene glycol, 2-hydroxyethyl
methacrylate, ethylenediamine, acrylic acid, hexamethyldisilane and hexamethyldisiloxane,
were used in a radio frequency glow discharge plasma polymerization system. As a model
antiproliferative drug, mitomycin-C was chosen for covalent coupling onto the stent surface.
Modified SS 316L stents were characterized by water contact angle measurements
(goniometer) and x-ray photoelectron spectroscopy. C1s binding energies showed a good
correlation with the literature. Haemocompatibility tests of coated SS 316L stents showed
significant latency (t-test, p < 0.05) with respect to SS 316L and control groups in each test.
(Some figures in this article are in colour only in the electronic version)
Introduction
In today’s developing world, coronary artery disease (CAD) is
the leading cause of cardiovascular mortality worldwide, with
over 5 million deaths per year. The risk factors of CAD rise
rapidly and continuously in developing countries [1]. CAD
is conditioned with the deposition of fibro-fatty clusters—also
known as atherosclerotic plaques—in the coronary arteries,
preceded and accompanied by inflammation. Atherosclerosis
is a chronic and widespread immunoinflammatory disease
7 Author to whom any correspondence should be addressed.
of large- and medium-sized arteries fuelled by atherogenic
lipoproteins, in particular modified LDL [2, 3]. The common
non-surgical treatment is percutaneous transluminal coronary
angioplasty (PTCA). The treatment of balloon angioplasty
with intravenous metallic stents for cardiovascular system
diseases has been the method of choice in the world with
bypass surgery, but some complications exist that threaten
human health and clash with the solution of metallic stents
[4–9].
Early restenosis is still one of the major clinical problems
of stent implantations with a 30% incidence in the first
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three months following the operation [4, 5]. Secondary
complications are coagulation on the metallic surface,
inflammation of tissues and release of toxic metal ions and
complexes by corrosion of the metal surface [6]. The
implantation causes arterial wall injury. The steel stent itself
has a thrombogenic nature. To minimize these complications
and to provide maximum biocompatibility of metallic stents
for human health has been a major goal since the discovery of
the implantation method by biocompatible material sciences
and medicine. The term biocompatibility is a phenomenon
that occurs at the interface between the biomaterial and the
host tissues. Although bulk properties dictate the mechanical
properties of biomaterials, tissue–biomaterials interactions are
surface phenomena and are governed by surface properties.
These interactions have been hypothesized to occur within
a narrow zone of less than 1 nm [10]. Biomaterials
must possess bulk properties that meet other requirements,
especially mechanical properties in order to have a proper
function in its environment. To eliminate complications
and increase biocompatibility, alternative and more effective
surface modification techniques have been discovered [11–13].
Stainless steel is still the most widely used material for
manufacturing intracoronary stents; however it is insufficient
in haemocompatibility. There are numerous examples in
the literature related to the disadvantages of metallic stents
[14–17]. The modification of stent surfaces can be made with
many techniques such as dipping, electrospraying, chemical
vapour deposition, physical vapour deposition, plasma ion
immersing and spraying. The stent modifications with
methods mentioned above have many examples in the past
two decades. Yoshioka et al reported that alginic acid coating
onto SS 316L stents reduces platelet adhesion by up to 75%
[18]. The stents which were coated with titanium nitric oxide
by the physical vapour deposition method decreased vessel
narrowing up to 45% compared with a negative control [19].
Spraying of active agents containing polymer solutions is
also a useful approach in the surface treatment of stainless
steel stents [20]. The thickness of casted polymer and
adhesion forces play key roles in the effectiveness of surface
modification. Coating by dipping and solvent-casting methods
can result in a lack of uniformity, and also the thickness of
the coating greater than the desired values makes the surface
act as a bulky structure. Poor adhesion of a polymeric
coating material onto the stent surface may cause it to
delaminate under the dynamic conditions of bloodstream.
Recently, surface modifications related to plasma processes
have produced good and promising results. Radio frequency
plasma treatment offers an advantageous mechanism to alter
the surface properties of biomaterials and medical devices
without affecting the mechanical properties of bulk structures.
Such coatings are tightly adherent, conformal and easily
applied. They also exhibit excellent biocompatibility qualities
[21]. Saito et al reported that fluorinated diamond-like
carbon films via the plasma-aided chemical vapour deposition
technique could be a promising candidate for blood-contacting
interventional devices with a dramatic decrease in the number
of adhering platelets with respect to the untreated samples
[22]. Plasma treatment of stainless steel stents before coating
with drug-eluting polymers incorporates functional groups that
prevent the polymeric films from delaminating from the stent
surface [23].
The surface treatment of 316L-type stainless steel stents
was carried out with six different materials (polyethylene
glycol (PEG), 2-hydroxyethyl methacrylate (HEMA),
ethylenediamine (EDA), hexamethyldisilane (HMDS),
hexamethyldisiloxane (HMDSO) and acrylic acid (AA)) by
plasma-aided deposition. The polymeric precursors above
were previously studied with blood-containing biomaterials,
especially with the radio frequency glow discharge (RFGD)
method [24–27]. The literature and commercial products
have numerous examples on drug variety but lack data on
covalently coupled active agent studies. Mitomycin C (MMC)
is a potent DNA crosslinker and is used in several cancer
therapies intravenously. Because of having antimitogenic
ability, MMC was also previously used in in vivo vascular
inflammation and neointimal hyperplasia studies [28, 29].
Immobilization of the anticoagulant and antimitogenic
agents on the stent surface using biodegradable ester or
peptide bonds allows a sustained release of the agents [30].
The purpose of this study was to generate different surface
characteristics and functional groups on the surface which
can be useful for covalent coupling of bioactive agents
subsequently.
Experimental details
Surface pre-cleaning of SS 316L stents
To avoid any interfering ion or radical that would come
from the impurities of the surface during the plasma surface
modification, the surfaces were pre-cleaned with piranha
solution consisting of sulfuric acid (98% w/w) and hydrogen
peroxide (30% w/w) in a 3:1 ratio for 5 min [20]. The pre-
cleaned stents were then rinsed with distilled water two times
for 10 min in a water sonication bath. The pre-cleaned SS
316L stents were dried in a vacuum oven and kept in closed
glassware.
Plasma modification of SS 316L stents
The surface of the SS 316L stents were modified with the
RFGD plasma deposition technique. A plasma modification
system (Vacuum Praha, Czech Republic) was equiped with
a 13.56 MHz radio frequency generator. The plasma reactor
was attached with a vacuum pump for the evacuation of reactor
gas. The reactor was fed with a monomer tank and argon gas
during the process.
In the surface modification method six different
monomers and prepolymers, AA (Acros, Belgium), PEG
(Acros, Belgium, Mw = 300), HEMA (Aldrich, USA), EDA
(Fluka, USA), HMDS and HMDSO (Merck, Germany), were
used at two different power levels (25 and 50 W) and for a
10 min timeline.
The stents were placed perpendicularly onto a stereofoam
support deployed in the middle of the electrodes with 1 cm
spaces between each of the species. Argon gas was passed
through the reactor at 0.1 mbar pressure to sweep away any
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reactive species like oxygen and nitrogen. Subsequently, the
reactor was fed with a coating polymer and the glow discharge
initiated at two power levels (25 and 50 W). The plasma
process lasted for 10 min and argon gas was passed through
the chamber again to sweep away any gaseous residue. The
stents were kept in vacuum for 10 min for the stabilization of
the coating.
Mitomycin-C immobilization
The 316L stents containing –COOH groups, the surfaces
of which were modified with AA, were incubated
in 1% EDAC·HCl (1-[3-dimethyl aminopropyl]-3-ethyl
carbodiimide hydrochloride) solution in 0.05 M MES (n-
morpholino ethanosulfonic acid) for the activation of the
–COOH functional groups generated by modification. After
the incubation, mitomycin-C solution (0.02%) was added into
the media for a direct covalent linkage of mitomycin-C via
the –NH2 functional groups. The procedure was carried out at
4 ◦C.
Surface characterization of stents
The bare metal stents and the surface-modified stents were
characterized with a sessile drop contact angle measurement
for the evaluation of hydrophilicity and x-ray photoelectron
spectroscopy (XPS) for the characterization of the chemical
surface composition by using plaques of 316L stainless steel.
The contact angles of the plaque surfaces were measured by the
sessile drop technique. The measurement apparatus consisted
of a camera and camera lens (Hitachi, Japan), a sample
platform and a water-dropping syringe. In the measurements,
deionized water was used. The resulting images were analysed
by using the ImagePro software (USA). The contact angles (θ )
of the surfaces were calculated with the formula
θ/2 = arctan 2h/d.
Measurements were repeated at least 10 times and the
results were given as averages with standard deviations.
Student’s one-tailed t-test was employed to test the statistical
significance of the contact angle measurements.
The XPS analysis of the stents was carried out in a Thermo
Scientific K-Alpha x-ray photoelectron spectrometer, which
utilizes monochromated Al K-alpha x-rays (1486.6 eV) to
strike the sample surface. The analyser pass energy was 50 eV
for the high-resolution core-level spectra and the beam spot
was 400 μm. The curve fitting of the spectra was performed
with the Thermo Avantage v4.41 software. A Shirley-type
correction was applied to the background under all fitted peaks.
In vitro cytotoxicity assay
The prepared surface-modified SS 316L stents were subjected
to an in vitro cytotoxicity test to investigate whether they had
any serious cytotoxic effect on cell proliferation or not. 1 ×
2 cm stents were incubated with equal amounts of precultured
mouse connective tissue fibroblast cells (L-929 cell line, Foot-
and-Mouth Disease Institute of Ministry of Agriculture and
Rural Affairs of Turkey) in growth media consisting of 90%
RPMI 1640 with L-glutamine and 10% FBS (Bio-Industries,
USA) in an incubator (Revco, USA) supplied with 5% CO2 at
37 ◦C for 2 days [19]. Then the monolayer growing cells were
harvested by using a trypsin–EDTA solution (Bio-Industries,
USA) and immediately suspended in fresh cell growth media.
0.5 ml of cell suspension was mixed with 0.5 ml of 0.4%
trypan blue solution (Bio-Industries, USA). The mixture was
vortexed to obtain a homogeneous solution, and both viable
(colourless) and non-viable (blue) cells were counted using a
Thoma Haemocytometer.
The cell proliferation was investigated for three days and
the results were compared with control groups.
In vitro haemocompatibility tests
Whole blood was collected from a healthy donor into 5 ml
citrated (75 mm) tubes and centrifuged at 4000 rpm for 7 min
at room temperature to obtain platelet poor plasma (PPP). The
samples placed in a polystyrene 24-well plate dish were in
contact with 1 ml of PPP for 30 min at 37 ◦C [18]. The
activated partial thromboplastin time (APTT), prothrombin
time (PT) and fibrinogen time were determined using an
automated blood coagulation analyser (Diagnostica Stago,
France). The measurements were triplicated. Student’s one-
tailed t-test was employed to test the statistical significance
of the PT, APTT and fibrinogen time measurements. The
individual measurements for each modification were compared
to the measurements of the bare SS 316L. Three independent
measurements had been utilized for the assessment of
significance. The p cut-off value was selected as 0.05 for
significance.
Results and discussion
Surface characterization of SS 316L stents
High-resolution scans of surfaces were taken at the C1s
spectrum, to determine the types of carbon species of the
surfaces. Figures 1(A)–(F) show the high-resolution C1s
scans for the various modified stent surfaces. All species
contain C–H aliphatic hydrocarbon bond at 285 eV due to
carbon backbones. C1s scans of the HEMA-, PEG- and AA-
modified surfaces show similar spectra and approximately the
same amounts of C–H (285.2 eV), C–O (286.8 eV) and C=O
(288.9 eV) [31]. The characteristic C–Si bond appeared after
low-energy argon ion sputtering for the HMDS and HMDSO
samples was carried out for 30 s at 282.9 eV [32] for each
spectrum with a small C–O impurity in the HMDS coating at
286.8 eV. The EDA-modified surfaces have both a C–N peak
at 288.6 eV in C1s scans and N–H bonds at 399.3 eV. Due
to oxidation of the surfaces, oxygen was found in O1s scans
in all species as O–Si, O–H and O–C at 530.4 eV, 532.8 eV
and 533.1 eV, respectively. The atomic percentages of oxygen
were found to be relatively larger when the polymerization
precursor contained oxygen itself (PEG, HEMA, AA and
HMDSO). The results are tabulated in table 1.
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Figure 1. High resolution C1s spectra of the modified samples.
Contact angle measurements of SS 316L stents
Figure 2 shows the contact angles of the surfaces of SS
316L stents, which were determined by the sessile drop
technique. The spreading drop shapes of water indicate the
hydrophilicity of the surface. The individual measurements for
each modification had been compared to the measurements of
the bare SS 316L. Ten independent measurements had been
utilized for the assessment of significance. The p cut-off value
has been selected as 0.01 for significance (figure 2).
The bare SS 316L plaque has a 91.6◦ water contact
angle and has poor wettability properties. Surface wettability
was found to be changed by the used monomers in both an
increasing and decreasing manner with respect to the different
functional groups. The results show that the monomers which
have polar and hydrophyl groups such as –OH, –NH2 and
C=O caused a decrease in the contact angle. –CH3, functional
group and Si-based structure containing plasma modifications
generated more hydrophobic surfaces. The surface wettability
increased with the decrease in contact angle [33].
The most wettable surface was found to be pls-PEG SS
316L with a discharge power of 50 W. The contact angle is
44.5◦ for the 50 W pls-PEG SS 316L, which means that it
has a hydrophilic character. The functional group –OH is
the most hydrophilic group among the used polymers. Other
4
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Figure 2. Contact angle values of the samples.
Table 1. Elemental analysis of the samples.
Atomic percentage Binding
Element (peak) pls-PEG pls-HEMA pls-EDA pls-HMDS pls-HMDSO pls-AA energy (eV) Assignment





N(1s) 0 0 23.5 0 0 0 399.3 N–H
400.5 N–C
O(1s) 34.2 24.2 18.7 12.8 32.5 35.7 530.4 O–Si
532.8 O–H
533.1 O–C
Si(2p) 0 0 0 33.4 44.3 0 102.5 Si–C
102.8 Si–Si
103.4 Si–O
coatings which decreased the water contact angle of SS 316L
are EDA and HEMA as 58.2◦ and 65.6◦, respectively, at
50 W discharge power. –NH2 in EDA and –OH and C=O in
HEMA play a role in increasing surface wettability. Surface
wettability was decreased with the increase in discharge power
in the EDA modification as can be seen in figure 2.
The lowest wettable surface modification was obtained
by the HMDSO plasma at 50 W discharge power. The
contact angle of this modified surface is 103.7◦ and it is more
hydrophobic than the bare SS 316L itself. Also the plasma-
assisted HMDS surface modifications generated hydrophobic
surfaces with contact angles of 88.5◦ and 90.5◦ at 25 W
and 50 W discharge powers, respectively. The results show
that the silicone-based plasma-assisted modifications generate
hydrophobic surfaces. The surface wettability order occurred
as
Pls − PEG SS 316L > Pls − EDA SS 316L
> Pls − AA SS 316L > Pls − HEMA SS 316L
> Pls − HMDS SS316L > unmodified bare SS 316L
> Pls − HMDSO SS 316L.
In vitro cytotoxicity assay
In vitro cell proliferation test was applied to the plasma-
modified SS 316L stents. The results are shown in figure 3.
There were no serious cytotoxic effects on the cell proliferation
of the species that interacted with the surface-modified stents.
Except for the drastic decrease in relative cell proliferation
value of the AA–MMC stent, we can say that the antimitogenic
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Figure 3. Cytotoxicity results of the samples.
Figure 4. Prothrombin time results of the samples.
effect of mitomycin-C drug had inhibited the mitogenic
procedure as a potent DNA crosslinker (figure 3).
Blood coagulation tests of SS 316L stents
PT, APTT and fibrinogen time measurements are essential
haemocompatibility tests for the behaviour of a biomaterial
that is in contact with blood [18, 34].
These tests were applied to the materials to evaluate the
effect of modifications in the coagulation cascade.
Figures 4–6 show the values of PT, APTT and fibrinogen
time of the plasma in contact with the samples.
Prothrombin, which is a precursor to thrombin, is a
coagulation (clotting) factor needed for the normal clotting of
blood. The prothrombin time is commonly used as a method
of monitoring the accuracy of the blood-thinning treatment
with anticoagulants. The reference range for this test time
is generally around 12–15 s. The values measured for the
materials were close to the control shown in figure 4, but pls-
HEMA SS 316L have an increasing effect with respect to bare
SS 316L on PT, which belongs to the extrinsic coagulation
pathway about 0.5 s (p < 0.05). Pls–EDA SS 316L have a
decreasing effect on PT about 0.4 s with respect to SS 316L,
which means the surface has some activating properties on the
extrinsic coagulation pathway (p < 0.05).
APTT is a blood test that measures how long it takes for
blood to clot. It is the main test that reveals the clotting time
problems. The test is essential for the biocompatibility of
material. The biomaterials that trigger host response shorten
the test time. In the values of the APTT pls-HMDS SS 316L,
Figure 5. Activated partial thromboplastin time results of the
samples.
Figure 6. Fibrinogen time results of the samples.
pls-HMDSO SS 316L and pls-HEMA SS 316L, there are
elevations in clotting time with respect to the values of the
unmodified SS 316L stents as 1.3, 1.4 and 2.6 s, respectively
(figure 5) (p < 0.05). The results indicate an adsorption of
proteins related to the intrinsic coagulation pathway [18].
In figure 6, there are some differences in clotting time
in the measurements of the fibrinogen test. Fibrinogen is
usually carried out with other blood clotting tests. Fibrinogen
levels are a reflection of the clotting ability and activity in
the body. For pls-HEMA SS 316L with pls-EDA SS 316L,
which again refer to an adsorption of plasma proteins that
are involved with the intrinsic coagulation pathway [18],
the clotting time increases by 2.1 and 1.1 s, respectively,
with respect to unmodified bare SS 316L stents (p < 0.05).
In contrast, the clotting time shortened in pls-HMDSO and
pls-AA modifications by 0.5 and 0.8 s, respectively, which
indicates that the surface characteristics of these materials have
inducing properties of fibrin formation (p < 0.05).
Conclusion
In this work, we reported that bare stents would be
more effective and biocompatible with the surface treatment
technique and further biomodifications. For altering the
host response, mitomycin-C was selected as the model drug.
Mitomycin-C is a well-known anticancer drug and also has
some potent inhibitor effects against vascular smooth muscle
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cell proliferation and neointima formation after arterial injuries
[35, 36].
The coating of the SS 316L stents with polymeric
materials was carried out in the study. The new surface
properties showed good compatibility with an increase in
wettability of some modifications with no cytotoxic effect on
cell proliferation. Although different gas plasma treatments
were applied to the material surfaces to incorporate different
functional groups, there is no clear correlation between
them and the blood surface reactions. However, our results
demonstrate that there are some relative chemical changes for
reducing protein activation events that are involved with the
coagulation cascade. The resulting coatings herein provide a
form of materials that stands between the bare metal stents and
drug-eluting stents. With the functional groups that exist on
the surface of the coating, we expect that it will be possible
to bind any anticoagulant or antimitogenic agents related with
CAD and have an opportunity to develop intracoronary stents
in an alternative way.
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